Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
27
Filosofía
14
Libre albedrío y determinismo
10
Jazz
9
Música popular
9
Aspectos económicos
8
Sociología
8
Etnología
7
Comercio
6
Aspectos psicológicos
5
Aspectos sociales
5
Cambio social
5
Ciudades y pueblos
5
Libre comercio
5
Modelos matemáticos
5
Política económica
5
Política gubernamental
5
Abuso de drogas
4
Administración
4
Ciencias sociales
4
Condiciones sociales
4
Democracia
4
Educación
4
Filosofía de la mente
4
History
4
Inglés
4
Mercadotecnia
4
Política y gobierno
4
Sistemas operativos (Computadoras)
4
Urbanismo
4
-
485641por Brastianos, Harry C., Nguyen, Paul, Sahgal, Arjun, Eisenhauer, Elizabeth A., Baetz, Tara, Hanna, Timothy P.“…MAIN OUTCOMES AND MEASURES: Overall survival, whole-brain radiotherapy-free survival, and time to subsequent brain treatment. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485642Publicado 2018“…Except patients receiving HSCT, the median leukemia-free survival (LFS) time for patients in D-CAG group and CAG group was 18.0 (95%CI 6.6–29.4) months and 11.0 (95%CI 0–23.9) months respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485643Publicado 2016“…With the follow up to 20 June 2015, the overall survival (OS), progression free survival (PFS) and prognostic factor were analyzed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485644Publicado 2017“…METHODS: The response, NPM1 mutated transcript level after induction chemotherapy and the first 2 cycles of consolidation chemotherapy, disease-free survival (DFS) and overall survival (OS) in 137 patients with AML with NPM1 mutations of A, B and D were retrospectively analyzed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485645por Botticelli, Andrea, Cirillo, Alessio, Scagnoli, Simone, Cerbelli, Bruna, Strigari, Lidia, Cortellini, Alessio, Pizzuti, Laura, Vici, Patrizia, De Galitiis, Federica, Di Pietro, Francesca Romana, Cerbelli, Edoardo, Ghidini, Michele, D’Amati, Giulia, Della Rocca, Carlo, Mezi, Silvia, Gelibter, Alain, Giusti, Raffaele, Cortesi, Enrico, Ascierto, Paolo Antonio, Nuti, Marianna, Marchetti, Paolo“…Regarding the progression free survival (PFS), using a UVA of the tumor burden (p = 0.0004), bone (p = 0.0098) and brain (p = 0.0038) metastases, the presence of other metastatic sites (p = 0.0063), the number of metastatic sites (p = 0.0007), the histology (p = 0.0007), the use of immunotherapy as first line (p = 0.0031), and the ECOG PS ≥ 1 (p ≤ 0.0001) were associated with a lower PFS rate. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485646por Sun, Xiaolei, Li, Xueping, Qi, Hongzhao, Hou, Xin, Zhao, Jin, Yuan, Xubo, Ma, Xinlong“…METHODS: Based on the presence of matrix metalloproteinases that are overexpressed at the fracture site, we designed the matrix metalloproteinase–sensitive nanocapsules which were formed by in situ free radical polymerisation on the surface of MiR-21 with 2-(methacryloyloxy) ethyl phosphorylcholine and the bisacryloylated VPLGVRTK peptide. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485647por Motzer, Robert J, Escudier, Bernard, McDermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Powles, Thomas, Donskov, Frede, Plimack, Elizabeth R, Barthélémy, Philippe, Hammers, Hans J, George, Saby, Grünwald, Viktor, Porta, Camillo, Neiman, Victoria, Ravaud, Alain, Choueiri, Toni K, Rini, Brian I, Salman, Pamela, Kollmannsberger, Christian K, Tykodi, Scott S, Grimm, Marc-Oliver, Gurney, Howard, Leibowitz-Amit, Raya, Geertsen, Poul F, Amin, Asim, Tomita, Yoshihiko, McHenry, M Brent, Saggi, Shruti Shally, Tannir, Nizar M“…Primary endpoints: overall survival (OS), progression-free survival (PFS), and objective response rate (ORR) per independent radiology review committee in IMDC intermediate-risk/poor-risk patients. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485648Publicado 2017“…There were no significant differences of erythrocyte and platelet transfusions (P=0.074, P=0.059) within 1 month after transplantation. ②There were no significant differences with regard to the incidences of acute GVHD[23.1% (15/65) vs 34.8% (32/92), P=0.115], chronic GVHD[20.0% (13/65) vs 32.6% (32/92), P=0.081], Ⅱ–Ⅳ degree of acute GVHD[30.0% (13/65) vs 30.4% (30/92), P=0.287] and extensive chronic GVHD[9.2% (6/65) vs 20.7% (19/92), P=0.135] between PEG-rhG-CSF and rhG-CSF groups. ③There were no significant differences in terms of disease free survival (DFS) (62.5% vs 61.4%, P=0.478) and overall survival (OS) (67.4% vs 67.3%, P=0.718) between PEG-rhG-CSF and rhG-CSF groups. ④There was no significant difference of the non-relapse mortality (NRM) between PEG-rhG-CSF and rhG-CSF groups[20.5% (95%CI 11.4%–37.0%) vs 32.6% (95%CI 22.2%–47.9%), P=0.141]. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485649por Munoz, Camila, Bustin, Aurelien, Neji, Radhouene, Kunze, Karl P., Forman, Christoph, Schmidt, Michaela, Hajhosseiny, Reza, Masci, Pier-Giorgio, Zeilinger, Martin, Wuest, Wolfgang, Botnar, René M., Prieto, Claudia“…The method was validated in patients with known or suspected cardiovascular disease, showing good agreement with conventional breath-held 2D LGE imaging, but offering higher spatial resolution, improved volumetric coverage and good image quality from a free-breathing acquisition with 100% scan efficiency and predictable scan time.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485650por Wang, Liqiang, Xu, Fei, Song, Zhenfeng, Han, Dan, Zhang, Jingyi, Chen, Linjun, Na, Lixin“…Blood insulin, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) levels were measured by enzyme-linked immunosorbent assay methods. Free fatty acids (FFAs) profiles in blood and liver were determined by using gas chromatography-mass spectrometry. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485651por Pagnini, Francesco, Bonanomi, Andrea, Tagliabue, Semira, Balconi, Michela, Bertolotti, Mauro, Confalonieri, Emanuela, Di Dio, Cinzia, Gilli, Gabriella, Graffigna, Guendalina, Regalia, Camillo, Saita, Emanuela, Villani, Daniela“…EXPOSURES: Information was collected from citizens living in the quarantine zone (ie, red zone), area with restricted movements (ie, yellow zone), and COVID-19–free regions (ie, green zone). MAIN OUTCOMES AND MEASURES: Levels of knowledge on the virus, contagion-related worries, social appraisal, and preventive behaviors were assessed with ratings of quality of life (measured using the Short Form Health Survey). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485652por Graham, Amanda L, Papandonatos, George D, Jacobs, Megan A, Amato, Michael S, Cha, Sarah, Cohn, Amy M, Abroms, Lorien C, Whittaker, Robyn“…METHODS: We conducted a 2×2×2×2 full factorial screening experiment wherein 864 participants were randomized to 1 of 16 experimental conditions after registering with a free internet smoking cessation program and enrolling in its automated text message program. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485653por He, Ruxuan, Mo, Ruo, Shen, Ming, Kang, Lulu, Song, Jinqing, Liu, Yi, Chen, Zhehui, Zhang, Hongwu, Yao, Hongxin, Liu, Yupeng, Zhang, Yao, Dong, Hui, Jin, Ying, Li, Mengqiu, Qin, Jiong, Zheng, Hong, Chen, Yongxing, Li, Dongxiao, Wei, Haiyan, Li, Xiyuan, Zhang, Huifeng, Huang, Min, Zhang, Chunyan, Jiang, Yuwu, Liang, Desheng, Tian, Yaping, Yang, Yanling“…During long-term follow-up, plasma total homocysteine (tHcy) levels were significantly higher in patients in the uncontrolled group than those in the seizure-free group. CONCLUSIONS: Most cblC patients caused by MMACHC c.609G > A homozygous mutation showed early-onset. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485654por Eriksen, Rebeca, Perez, Isabel Garcia, Posma, Joram M., Haid, Mark, Sharma, Sapna, Prehn, Cornelia, Thomas, Louise E., Koivula, Robert W., Bizzotto, Roberto, Prehn, Cornelia, Mari, Andrea, Giordano, Giuseppe N., Pavo, Imre, Schwenk, Jochen M., De Masi, Federico, Tsirigos, Konstantinos D., Brunak, Søren, Viñuela, Ana, Mahajan, Anubha, McDonald, Timothy J., Kokkola, Tarja, Rutter, Femke, Teare, Harriet, Hansen, Tue H., Fernandez, Juan, Jones, Angus, Jennison, Chris, Walker, Mark, McCarthy, Mark I., Pedersen, Oluf, Ruetten, Hartmut, Forgie, Ian, Bell, Jimmy D., Pearson, Ewan R., Franks, Paul W., Adamski, Jerzy, Holmes, Elaine, Frost, Gary“…However, understanding the efficacy of dietary interventions is confounded by the challenges inherent in assessing free living diet. Here we profiled dietary metabolites to investigate glycaemic deterioration and cardiometabolic risk in people at risk of or living with T2D. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485655por Rühle, Alexander, Grosu, Anca-L., Wiedenmann, Nicole, Mix, Michael, Stoian, Raluca, Niedermann, Gabriele, Baltas, Dimos, Werner, Martin, Weber, Wolfgang A., Kayser, Gian, Nicolay, Nils H.“…The impact of the PD-1/PD-L1 expression alone and in combination with persistent tumor hypoxia on locoregional control (LRC), progression-free survival (PFS) and overall survival (OS) was examined using log-rank tests and Cox proportional hazards models. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485656por Welch, Barrett M., Keil, Alexander P., van ‘t Erve, Thomas J., Deterding, Leesa J., Williams, Jason G., Lih, Fred B., Cantonwine, David E., McElrath, Thomas F., Ferguson, Kelly K.Enlace del recurso
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485657por Belbin, Olivia, Xiao, Mei-Fang, Xu, Desheng, Carmona-Iragui, Maria, Pegueroles, Jordi, Benejam, Bessy, Videla, Laura, Fernández, Susana, Barroeta, Isabel, Nuñez-Llaves, Raúl, Montal, Victor, Vilaplana, Eduard, Altuna, Miren, Clarimón, Jordi, Alcolea, Daniel, Blesa, Rafael, Lleó, Alberto, Worley, Paul F., Fortea, Juan“…We determined the relationship of CSF NPTX2 levels to age, cognitive performance (CAMCOG, free and cued selective reminding, semantic verbal fluency), CSF levels of a PV-interneuron marker (GluA4) and core AD biomarkers; CSF Aβ(1–42), CSF t-tau, cortical atrophy (magnetic resonance imaging) and glucose metabolism ([(18)F]-fluorodeoxyglucose positron emission tomography). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485658por Chen, Yalei, Sadasivan, Sudha M., She, Ruicong, Datta, Indrani, Taneja, Kanika, Chitale, Dhananjay, Gupta, Nilesh, Davis, Melissa B., Newman, Lisa A., Rogers, Craig G., Paris, Pamela L., Li, Jia, Rybicki, Benjamin A., Levin, Albert M.“…Unsupervised hierarchical clustering of the copy number of genes residing in race-differentiated SCNAs shared between tumor types was used to identify SCNA-defined patient groups, and Cox proportional hazards regression was used to test for association between those groups and overall/progression-free survival (PFS). RESULTS: We identified SCNAs that differed by race in breast (n = 58 SCNAs; permutation p < 10(− 4)) and prostate tumors (n = 78 SCNAs; permutation p = 0.006). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485659Publicado 2020“…The infection rates of CMV and EBV in the ATG-9 group (77.2% and 12.5%) were significantly higher than those in the ATG-6 (43.3% and 3.5%), and ATG-7.5 group (44.4% and 1.5%) (P<0.001 and P=0.033, respectively). ③Among the three groups, there were no significant difference in the 3-year overall survival [68.5% (95% CI 60.3%–77.9%), 60.1% (95% CI 48.3%–74.8%), 64.7% (95% CI 51.9%–80.7%)], cumulative incidences of relapse [34.6% (95% CI 34.3%–35.1%), 38.0% (95% CI 37.3%–38.7%), 20.6% (95% CI 20.0%–21.3%)], disease-free survival [53.3% (95% CI 44.9%–63.4%), 51.9% (95% CI 41%–65.8%), 63.9% (95% CI 51.9%–78.7%)] and non-relapse mortality [24.2% (95% CI 23.8%–24.5%), 26.0% (95% CI 25.4%–26.6%), 23.6% (95% CI 26.3%–28.2%)] (P=0.648, P=0.165, and P=0.486 and P=0.955). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485660por Williams, Brent A., Chamberlain, Alanna M., Blankenship, James C., Hylek, Elaine M., Voyce, Stephen“…Among 500 684 patients free of AF at baseline, standardized AF incidence rates from 2006 to 2018 increased from 4.74 (95% CI, 4.58-4.90) to 6.82 (95% CI, 6.65-7.00) cases per 1000 person-years, increasing significantly over time (P < .001). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto